Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02232438

Psychotherapy for Depressed or Anxious Adolescents With Cancer

Open Trial of Behavioral Activation Therapy for Depressed or Anxious Adolescents With Cancer

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
New York State Psychiatric Institute · Academic / Other
Sex
All
Age
12 Years – 21 Years
Healthy volunteers
Not accepted

Summary

At present, there are no established treatments for depression or anxiety in adolescents with cancer, creating an important clinical and research gap. Fortunately, there is now substantial evidence documenting the efficacy of psychotherapy in the treatment of depressed and anxious adolescents in the general population.

Detailed description

Despite the high prevalence of depression and anxiety in cancer patients, little is known about the efficacy of psychotherapy in depressed and anxious adolescents with cancer. Behavioral activation therapy (BAT) is a brief, manualized therapy that has shown efficacy in the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD) in several controlled trials patients, including adult cancer patients. The goal of this open label clinical trial is to obtain preliminary evidence of the efficacy of BAT(6 sessions) in a group of adolescent cancer patients with MDD, GAD or adjustment disorder with mood or anxiety features. We will test the efficacy of BAT using the Multidimensional Anxiety Scale for Children at several time points of the treatment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBehavioral activation therapyBehavioral activation therapy (BAT) is a brief, manualized therapy that has shown efficacy in the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD) in several controlled trials patients (see review in Dimidjan et al., Ann Rev Clin Psychol, 2010, and Chu, Brian C., et al. Cognitive and Behavioral Practice, 2009.), including adult cancer patients (Hopkoet al., 2009; Hopko et al., 2011).

Timeline

Start date
2015-01-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2014-09-05
Last updated
2015-10-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02232438. Inclusion in this directory is not an endorsement.